Abhijit S. Dighe, Ph. D Department of Orthopaedic Surgery University of Virginia SOM.

Slides:



Advertisements
Similar presentations
Chapter 62 Chapter 62 Mechanisms of Bone Destruction in Myeloma Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

Young Persons’ World Lecture Competition
“PRESERVATION OF BONE TECHNIQUE AND MATERIALS”
Medical Biotechnology Regenerative Medicine
THE USE OF STEM CELLS AS A REGENERATIVE THERAPY FOR CHRONIC LAMINITIS Nikki Engwall Penn State University.
rhBMP-2: origin, biology and preclinical safety
Stem Cells and Cell Signaling
Mesenchymal and Tissue-Specific Stem Cells ChemEng 590B: Tissue Engineering Lecture 4 January 31 st, 2013.
Cell Differentiation: Cell interactions in Development
Physiology of wound healing Wound healing is: – Complicated process that involves at least 4 distinct cell types – Commonly referred to as occurring in.
What is REGENERATIVE MEDICINE? “The regeneration or replacement of cells, tissues or organs to restore or establish normal function.” The goal is to.
Injectable Calcium Phosphate Cement
3 rd Annual Friedman Fellows Symposium November 13 th 2010 Pauline Suwandhi, M.D., Amit Seth, M.D., Ashutosh Pareek, D.O., Vanessa Sy, M.D., Leonid Poretsky,
Therapeutic Peptides for Cardiovascular Disease and Cancer Cam Patterson, MD, MBA, FACC, FAHA Ernest and Hazel Craige Distinguished Professor of Cardiovascular.
Effects of BMP-2 and -7 on Oral Squamous Carcinoma Cells 1 University of Michigan School of Dentistry, Ann Arbor, Michigan, USA; 2 Washington University.
Scaffolds, Growth Factors, and Tissue Constructs Hasan Uludag Department of Chemical & Materials Engineering, Department of Biomedical Engineering, and.
Stem Cells and Regenerative Medicine. “Glow-in-the-dark” dogs!
MESENCHYMAL STEM CELLS OR: HOW I LEARNED TO STOP WORRYING AND LOVE DIFFERENTIATION. Matthew Downs || 1/19/10.
ADULT STEM CELL DR ANDUJAR LPGN RESEARCH SCIENTIST.
This presentation will provide a brief introduction into stem cell technology. I hope that you enjoy the lecture. There will be several quiz questions.
Chapter 10 T-cell Maturation, Activation, and Differentiation
FDA Regulation of Combination Products Barbara D. Boyan, Ph.D. American Academy of Orthopaedic Surgeons Professor and Deputy Director for Research for.
Engineered Cells and Tissues Locksley McGann, PhD Professor Department of Laboratory Medicine and Pathology University of Alberta 24 April, 2012 Analytics,
Bone Morphogenetic Protein By: Kim Stephens. What is Bone Morphogenetic Protein? Stimulates a patient's own cells to induce the formation of bone and.
APS 2006 Refresher Course Common auto-immune signaling defects; what does gender have to do with it? Denise Faustman, M.D., Ph.D. Director, Immunobiology.
What are they and what can we do with them?
Health Biotechnology Stem Cell Therapeutics; Tissue Engineering LECTURE 21: Biotechnology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences.
Advances in osteoporosis treatment John C Stevenson National Heart & Lung Institute Imperial College London Royal Brompton Hospital London, UK.
Jason Ip Graduate Student
Shen Bin Journal Club. What is MSCs?  Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of.
Using Stem Cells to Treat Disease The first step: establish stem cell lines (large groups of the same cells) Next: turn on specific genes so that the stem.
Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm Lindsley R.C. et al, Development (2006)
(-)-EPIGALLOCATECHIN-3-GALLATE (EGCG) EHNAHCES OSTEOGENESIS IN A BONE MARROW MESENCHYMAL STEM CELL LINE Chung-Hwan Chen 1,3 ; Mei-Ling Ho 2,3 ; Je-Ken.
BMP Receptor 1A Juvenile Polyposis Dayna Neo 3/21/13 Biol
BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters.
Tissue dynamic and Morphogenesis Dept. Physiology Chang Gung University J. K. Chen, Professor.
Peter V Giannoudis MD, FRCS Professor & Chairman
Smad3-dependent nuclear translocation of B-catenin is required for TGF-B1-induced proliferation of bone marrow- derivced adult human mesenchymal stem cells.
Module 4: High Throughput Screen Presentation BENG 162 Group A6 December 11, 2014 Alex Boone, Derrick Buntin, Frank Fleming, Keith Hoffman.
Type 1 Diabetes Type 1 diabetes or “insulin dependent” diabetes is an autoimmune disease that results in destruction of insulin-producing beta cells of.
What are Stem Cells Three general properties: they are capable of dividing themselves for long periods; they are unspecialized; and they can give rise.
Stem Cell Identification Nozad H. Stem cell workshop Stem cell Research center Tabriz medical university In The Name of God.
Smad7-induced b-catenin degradation alters epidermal appendage development Han, G. et al., 2006, Dev Cell.
Dr Mark Chong National University of Singapore Dept of Obstetrics and Gynaecology.
Bone Morphogenetic Protein-7 Modulates Genes that Maintain the Vascular Smooth Muscle Cell Phenotype in Culture by Haimanti Dorai, and T Kuber Sampath.
Welcome To Our Presentation
Optimization of adenoviral transduction of the human muscle tissue for the development of ex vivo gene therapy Vesna Vetma 1, Maja Antunović 1, Igor Matić.
IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.
Dermal Regeneration Using Multipotent Adult Stem Cells
Yonca Yakut CHEM 442- Spring’12
Stem Cells: Scientific Potential and Alternatives
Dr Dimitrios Tsoukas MD, MSc
Center for Cellular and Molecular Biology, Hyderabad
Daratumumab Drugbank ID : DB09043.
Chapter 9 T-cell Development
BMI: Regenerative Medicine
Research Interest Group:
Stem cells in dentistry – Part II: Clinical applications
Bone Biology and Osteoporosis: Back to the Basics
How do cells talk to each other
DNA and the Genome Key Area 4b Stem Cells.
Bone Biology and Osteoporosis: Back to the Basics
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
BMP Receptor 1a and Juvenile Polyposis Syndrome
Bone Biology and Osteoporosis: Back to the Basics
Volume 24, Issue 2, Pages (February 2016)
Gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenesis DOI: /FHC.a Gene-act-network according.
Novel juvenile factors for cartilage regeneration
Stem cell Basics.
Claudia Loebel, Jason A. Burdick  Cell Stem Cell 
Presentation transcript:

Abhijit S. Dighe, Ph. D Department of Orthopaedic Surgery University of Virginia SOM

University of Virginia Orthopaedic Surgery Research interest: Regenerative potential of MSCs

University of Virginia Orthopaedic Surgery Research interests Stem cells signaling pathways that dictate differentiation into osteogenic lineage J Cell Physiol Mar 9. [Epub ahead of print]. Impact factor = 3.87 PLoS One :e Impact factor = Growth Factors : Impact factor = J Orthop Res : Impact factor = Stem cells surface markers, their functions, use of stem cells surface markers for selection of osteogenic stem cells J Orthop Res (5): Impact factor = Bone tissue engineering using gene therapy and stem cells Cell and tissue research Accepted for publication. Impact factor = Bone Marrow Res : Impact factor = Open access journal Curr Pharm Des : Impact factor = 3.55 Growth Factors : Impact factor = Growth Factors : Impact factor = Interaction between immune cells and stem cells during osteogenesis : use of allogeneic stem cells for bone regeneration Journal of Immunology Research :ID Impact factor = Journal of Immunology Research :ID Impact factor = J Orthop Res : Impact factor = 2.972

University of Virginia Orthopaedic Surgery Why study MSCs? Deficiencies associated with fracture non-unions Defective Mesenchymal stem cells (MSCs): -Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 (Dkk-1) secretion. -Decreased number in bone marrow, decreased proliferation. Defective Bone morphogenetic proteins (BMPs) signaling in MSCs: -Downregulation of gene expression of BMPs-2,3,4,6,7; noggin, germlin, sclerostin, BAMBI in experimental atrophic nonunions in rats. -Downregulation of gene expression of BMP-7 -Balance between local presence of BMPs and BMP-inhibitors; total absence of pSmads 1/5/8 in cartilage. Defective induction of bone formation by MSCs in presence of immune cells – new concept - T cells inhibit bone formation induced by MSCs

University of Virginia Orthopaedic Surgery Why study MSCs? Clinically speaking - AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 77TH ANNUAL MEETING, MARCH , 2010 NEW ORLEANS, LOUISIANA

University of Virginia Orthopaedic Surgery Why study MSCs? Clinically speaking -

University of Virginia Orthopaedic Surgery Potential need for allogeneic MSCs Pre-made Ready to use Off-the-shelf Osteoconductive Allogeneic MSCs Derived from- young healthy males Fracture non-unions Older patients People with osteoporosis, osteonecrosis, multiple myeloma, lupus, ALS, myelodysplastic syndromes, obesity Females Individuals on prescription medications (Antidiabetic - Rosiglitazone, thiazolidinediones; NSAID COX-2 inhibitors) People consuming alcohol in excess Basic & clinical research, clinical trials, FDA-approval

University of Virginia Orthopaedic Surgery Currently available FDA-approved MSCs-based cellular bone matrices (CBMs) (all data is shown exactly as reported by the individual companies; no extrapolations have been made)

University of Virginia Orthopaedic Surgery Caveats of current MSCs-based CBMs The manufacturers claimed that efficacy of the product did not depend on MSCs – probably only to avoid FDA premarket application (PMA) Since the currently marketed CBMs bypassed FDA premarket review, they did not undergo clinical trials - safety and efficacy is elusive. All are allogeneic MSCs-based – effectiveness of allogeneic MSCs is controversial The most expensive and only CBM using live source received warning from FDA in 2013 that Ovation does not meet 21 CFR Part – the production will stop in 1-2 years based on reports of FDA this year.

University of Virginia Orthopaedic Surgery Allogeneic MSCs do not work Mesenchymal stem cells 3 weeks 6 weeks Syngeneic Allogeneic

University of Virginia Orthopaedic Surgery T cells inhibit osteogenesis Treg cells promote osteogenesis

University of Virginia Orthopaedic Surgery Our long term goal is to produce an optimum (osteoconductive, osteoinductive, T cells-inhibiting, providing structural strength) deliverable, FDA-approved bone graft substitute for bone regeneration Goals

University of Virginia Orthopaedic Surgery Thank You